School of Medicine
Showing 1,421-1,440 of 1,598 Results
-
Alexis Thomas Weiner
Basic Life Research Scientist, Pathology Sponsored Projects
Current Research and Scholarly InterestsThe planar cell polarity (PCP) signaling pathway polarizes animal cells along an axis parallel to the tissue plane, and in so doing generates long-range organization that can span entire tissues. Although its core proteins and much about their interactions are known, how PCP signaling occurs at a mechanistic level remains fundamentally mysterious. In my current project I will employ novel genetic methods to dissect the logic underlying how cellular asymmetry arises at a molecular level.
-
Alexandre Raphael Wery
Postdoctoral Scholar, Hematology
Current Research and Scholarly InterestsAML. Measurable residual disease. Circulating tumor DNA. CAPP-Seq.
-
Philipp Wesp
Postdoctoral Scholar, Radiology
BioI am a postdoctoral researcher investigating interpretable machine learning (ML) and large language model (LLM) applications in clinical radiology. My current research focuses on two complementary areas: understanding what human-interpretable concepts self-supervised vision foundation models learn through mechanistic interpretability techniques like sparse autoencoders, and developing LLM-based systems, including agentic workflows and retrieval augmented generation (RAG) architectures, that leverage unstructured hospital data to improve radiological workflows. I earned my PhD from LMU Munich, where I focused on clinically motivated machine learning applications in medical imaging in the Department of Radiology.
My work is partially funded by a Walter Benjamin Fellowship from the DFG (German Research Foundation). -
McKenzie White
Postdoctoral Scholar, Radiology
BioI work at the intersection of machine learning, medical imaging, and biomechanics. I'm committed to developing tools that bridge gaps between computational methods, musculoskeletal research, and clinical care - enabling more precise analyses, efficient workflows, and improved surgical decision-making.
-
Shannon White
Postdoctoral Scholar, Genetics
BioHi, I'm Shannon White. I began my postdoctoral fellowship in Michael Snyder's lab in the fall of 2020. I received my PhD from Georgetown University in Tumor Biology in Chunling Yi's lab. My graduate worked explore the signaling and metabolic vulnerabilities of NF2-mutant tumors following YAP/TAZ depletion. My postdoctoral work is exploring the epigenetic hallmarks that contribute to colon cancer progression and drug resistance. I am developing colon organoids derived from pre-cancerous polyp tissue collected from Familial Adenomatous Polyposis patients as a model system to investigate epigenetic and signaling responses to chemoprevention treatments.
-
Lucy Whitmore
Postdoctoral Scholar, General Surgery
BioLucy Whitmore is a radiation physics researcher at Stanford University working on emerging radiotherapy technologies, with a particular focus on ultra-high dose-rate (FLASH) radiation delivery. Her research combines radiation dosimetry, preclinical irradiation, Monte Carlo simulation, accelerator physics, treatment planning, and quantitative analysis of radiation biology studies. She also works on very-high-energy electron beams, detector response, radiochromic film dosimetry, and the development of reproducible experimental and computational workflows for translational radiotherapy research.
-
Wesley Williams
Postdoctoral Scholar, Radiology
Current Research and Scholarly InterestsFirstly, a goal of mine is to fashion a novel scatter-based parameter for PET reconstruction algorithms to improve image resolution via determining a more detailed scatter/true ratio estimate via binning the photons that have scattered once, twice, and perhaps, many more times.
Secondly, AI drug discovery application towards radiotracers may quicken experimentation by determining the formulations worth trying. Moreover, it may be able to characterize efficacy (biodistribution) (self-update). -
Willemijn Witkam
Postdoctoral Scholar, Dermatology
BioI am a dedicated medical doctor from The Netherlands with a passion for research specializing in dermatology. My expertise spans epidemiology, exposome, microbiome, and genetics. During my postdoc at Stanford, I will study the associations of harmful environmental exposures (air pollutants, microplastics) on (inflammatory) dermatological diseases in the lab of Dr. Eleni Linos.
-
Emily Woods
Postdoctoral Scholar, Pathology
Current Research and Scholarly Interestsdevelopment of activity-based probes for specific diagnosis and treatment of Staphylococcus aureus infections and for detection of bacterial ear infections (otitis media)
-
Mulate Zerihun Workeneh
Postdoctoral Scholar, Critical Care
BioDr. Mulate Zerihun Workeneh is a Postdoctoral Scholar in Dr. Bereketeab Haileselassie’s laboratory in the Department of Pediatrics at Stanford University School of Medicine. He earned a Ph.D. in Medical Sciences from the Azrieli Faculty of Medicine at Bar-Ilan University, Israel, where he developed peptide therapeutics that target mitochondrial protein-protein interactions involved in cardiovascular disease. Dr. Workeneh’s research uses medicinal chemistry, chemical biology, peptide engineering, computational modeling and mitochondrial biology to understand how the disease occurs and to develop new ways to treat it. During his doctoral training, he designed and evaluated novel linear and macrocyclic peptide inhibitors that alter mitochondrial dynamics to mitigate mitochondrial dysfunction and cardiovascular injury. His work at Stanford is focused on defining the role of mitochondrial dynamics in endothelial dysfunction in sepsis and multiple organ dysfunction syndrome (MODS). He is working to develop peptide-based therapeutics that maintain mitochondrial function, improve vascular health and prevent organ failure in critically ill patients by integrating approaches in chemical biology, molecular and cellular biology, and translational drug discovery. Dr. Workeneh has publications in leading medicinal chemistry, pharmacology, and mitochondrial biology journals and is an inventor on patents related to mitochondrial protein-protein interaction inhibitors. His goal is to translate advances in mitochondrial biology into first-in-class therapeutics for cardiovascular disease, sepsis, and other disorders linked to mitochondrial dysfunction. He is excited to work across disciplines at Stanford to help push biomedical research forward.
